Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis
… Small cell lung cancer, the other main type of lung cancer, is nearly … lung cancers are not
detected until they are quite advanced, less than 10% of people diagnosed with lung cancer …
detected until they are quite advanced, less than 10% of people diagnosed with lung cancer …
[HTML][HTML] Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer—a meta-analysis
… Mutation burden in lung and other cancers is also … Interestingly, EGFR-mutated lung cancer
was shown to have low … for the finding of our meta-analysis. Immunogenicity of EGFR-mutant …
was shown to have low … for the finding of our meta-analysis. Immunogenicity of EGFR-mutant …
Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis
H Nakamura, N Kawasaki, M Taguchi… - … journal of cancer, 2005 - nature.com
… In conclusion, the present meta-analysis of published data disclosed that survival after
limited resection for stage I lung cancer is comparable to lobectomy. However, considerable …
limited resection for stage I lung cancer is comparable to lobectomy. However, considerable …
Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis
H Nakamura, K Ando, T Shinmyo, K Morita… - Annals of Thoracic and …, 2011 - jstage.jst.go.jp
… have better survival even in advanced stages, as shown in our meta-analysis. Among …
biologic features of lung cancer in women. In conclusion, our present meta-analysis of published …
biologic features of lung cancer in women. In conclusion, our present meta-analysis of published …
[HTML][HTML] Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis
… of previous meta-analyses … lung cancer. Any further studies should investigate the association
between specific types of fruits and vegetables and lung cancer risk and conduct analyses …
between specific types of fruits and vegetables and lung cancer risk and conduct analyses …
Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues
P Guan, Z Yin, X Li, W Wu, B Zhou - … of experimental & clinical cancer …, 2012 - Springer
… meta-analysis of human lung cancer miRNA expression profiling studies might provide some
clues of the potential biomarkers in lung cancer… and role in the development of lung cancer. …
clues of the potential biomarkers in lung cancer… and role in the development of lung cancer. …
Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis
… -related lung cancer in our main analysis did not differ in subgroup analyses stratified by
the women-to-men ratio of current smokers (p=0.90), women-to-men ratio of lung cancer …
the women-to-men ratio of current smokers (p=0.90), women-to-men ratio of lung cancer …
Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data
… It is noteworthy that the 65% overall frequency of aneuploidy, as observed in this metaanalysis
is consistent with the 67% frequency reported in 4941 patients suffering from various …
is consistent with the 67% frequency reported in 4941 patients suffering from various …
Selenium and lung cancer: a systematic review and meta analysis
H Fritz, D Kennedy, D Fergusson, R Fernandes… - PloS one, 2011 - journals.plos.org
… and prevention of lung cancers, but large chemoprevention trials have yielded conflicting
results. We conducted a systematic review of selenium for lung cancers, and assessed …
results. We conducted a systematic review of selenium for lung cancers, and assessed …
Chemotherapy vs supportive care in advanced non-small-cell lung cancer: results of a meta-analysis of the literature
P Marino, S Pampallona, A Preatoni, A Cantoni… - Chest, 1994 - Elsevier
… The treatment for advanced non-small-cell lung cancer (NSCLC) represents a frustrating
and distressing problem for the medical oncologist. For the last three decades, since the …
and distressing problem for the medical oncologist. For the last three decades, since the …